Summit Therapeutics Logo

Summit Therapeutics

🇺🇸
SMMT
US86627T1088

Summit Therapeutics is a US-based biopharmaceutical company specializing in the clinical development of innovative oncology therapies. The company focuses on researching and delivering novel drugs for solid tumors, particularly for patients with non-small cell lung cancer, to improve their treatment options.

Next Quarterly Earnings

Wednesday, August 12, 2026
CW 33
After-Hours
In 38 days

Stock Price

All Dates

Company Information

Name
Summit Therapeutics
Ticker Symbol
SMMT
ISIN
US86627T1088
Country
🇺🇸
USA